Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7914780
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
granted -
US 7906628
Targeting proteins to deliver therapeutic or diagnostic reagents
granted -
US 7897340
Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
granted -
US 7893033
Targeting proteins to deliver therapeutic or diagnostic reagents
granted -
US 7892567
Methods and compositions for immunization against chlamydial infection and disease
granted -
US 7887836
Compositions and methods for treating lymphoma
granted -
US 7884211
Dimeric small molecule potentiators of apoptosis
granted -
US 7879801
Compositions comprising cell-impermeant duramycin derivatives
granted -
US 7871775
Compositions and methods for the identification, assessment, prevention and therapy of human cancers
granted -
US 7863414
Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain
granted -
US 7863275
Uses of tetrahydrobiopterin and derivatives thereof
granted -
US 7858592
Interfering RNAs against the promoter region of P53
granted -
US 7854932
Immunogenic compositions comprising progastrin and uses thereof
granted -
US 7847084
VMP-like sequences of pathogenic Borrelia species and strains
granted -
US 7838691
Palmerolides: methods of preparation and derivatives thereof
granted -
US 7838511
Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
granted -
US 7838556
Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands
granted -
US 7829688
Peptides of CaV2.2 that inhibit pain
granted -
US 7829668
Compositions and methods for modifying toxic effects of proteinaceous compounds
granted -
US 7825269
Ligands for nematode nuclear receptors and uses thereof
granted -
US 7824697
High concentration baclofen preparations
granted -
US 7816131
Cancer specific promoters
granted -
US 7816324
Composition and method for the treatment of diseases affected by a peptide receptor
granted -
US 7816538
Dimeric small molecule potentiators of apoptosis
granted